Global Infectious Diseases Diagnostic Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: G25D4E6EC65FEN
QYResearch

Abstracts

This report focuses on the global Infectious Diseases Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Diseases Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Becton Dickinson & Company
• Cepheid, Inc.
• Abbott Laboratories
• bioMerieux SA
• Hologic, Inc.
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Roche Diagnostics
• Alera Inc.
• DiaSorin S.p.A.
• Quidel Corporation
• Bio-Rad Laboratories, Inc.

Market segment by Type, the product can be split into

• Urine
• Blood
• Others

Market segment by Application, split into

• Hospitals and Trauma Centers
• Diagnostic Laboratories
• Rehabilitation Centers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Infectious Diseases Diagnostic status, future forecast, growth opportunity, key market and key players.
• To present the Infectious Diseases Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Infectious Diseases Diagnostic are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infectious Diseases Diagnostic Revenue
1.4 Market Analysis by Type
  1.4.1 Global Infectious Diseases Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Urine
  1.4.3 Blood
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Infectious Diseases Diagnostic Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Trauma Centers
  1.5.3 Diagnostic Laboratories
  1.5.4 Rehabilitation Centers
1.6 Coronavirus Disease 2019 (Covid-19): Infectious Diseases Diagnostic Industry Impact
  1.6.1 How the Covid-19 is Affecting the Infectious Diseases Diagnostic Industry
    1.6.1.1 Infectious Diseases Diagnostic Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Infectious Diseases Diagnostic Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Infectious Diseases Diagnostic Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Infectious Diseases Diagnostic Market Perspective (2015-2026)
2.2 Infectious Diseases Diagnostic Growth Trends by Regions
  2.2.1 Infectious Diseases Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Infectious Diseases Diagnostic Historic Market Share by Regions (2015-2020)
  2.2.3 Infectious Diseases Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Infectious Diseases Diagnostic Market Growth Strategy
  2.3.6 Primary Interviews with Key Infectious Diseases Diagnostic Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Infectious Diseases Diagnostic Players by Market Size
  3.1.1 Global Top Infectious Diseases Diagnostic Players by Revenue (2015-2020)
  3.1.2 Global Infectious Diseases Diagnostic Revenue Market Share by Players (2015-2020)
  3.1.3 Global Infectious Diseases Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infectious Diseases Diagnostic Market Concentration Ratio
  3.2.1 Global Infectious Diseases Diagnostic Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Infectious Diseases Diagnostic Revenue in 2019
3.3 Infectious Diseases Diagnostic Key Players Head office and Area Served
3.4 Key Players Infectious Diseases Diagnostic Product Solution and Service
3.5 Date of Enter into Infectious Diseases Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Infectious Diseases Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Type (2021-2026)

5 INFECTIOUS DISEASES DIAGNOSTIC BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Infectious Diseases Diagnostic Market Size by Application (2015-2020)
5.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Infectious Diseases Diagnostic Market Size (2015-2020)
6.2 Infectious Diseases Diagnostic Key Players in North America (2019-2020)
6.3 North America Infectious Diseases Diagnostic Market Size by Type (2015-2020)
6.4 North America Infectious Diseases Diagnostic Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Infectious Diseases Diagnostic Market Size (2015-2020)
7.2 Infectious Diseases Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Infectious Diseases Diagnostic Market Size by Type (2015-2020)
7.4 Europe Infectious Diseases Diagnostic Market Size by Application (2015-2020)

8 CHINA

8.1 China Infectious Diseases Diagnostic Market Size (2015-2020)
8.2 Infectious Diseases Diagnostic Key Players in China (2019-2020)
8.3 China Infectious Diseases Diagnostic Market Size by Type (2015-2020)
8.4 China Infectious Diseases Diagnostic Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Infectious Diseases Diagnostic Market Size (2015-2020)
9.2 Infectious Diseases Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Infectious Diseases Diagnostic Market Size by Type (2015-2020)
9.4 Japan Infectious Diseases Diagnostic Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Infectious Diseases Diagnostic Market Size (2015-2020)
10.2 Infectious Diseases Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infectious Diseases Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Infectious Diseases Diagnostic Market Size by Application (2015-2020)

11 INDIA

11.1 India Infectious Diseases Diagnostic Market Size (2015-2020)
11.2 Infectious Diseases Diagnostic Key Players in India (2019-2020)
11.3 India Infectious Diseases Diagnostic Market Size by Type (2015-2020)
11.4 India Infectious Diseases Diagnostic Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Infectious Diseases Diagnostic Market Size (2015-2020)
12.2 Infectious Diseases Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Infectious Diseases Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Infectious Diseases Diagnostic Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Becton Dickinson & Company
  13.1.1 Becton Dickinson & Company Company Details
  13.1.2 Becton Dickinson & Company Business Overview and Its Total Revenue
  13.1.3 Becton Dickinson & Company Infectious Diseases Diagnostic Introduction
  13.1.4 Becton Dickinson & Company Revenue in Infectious Diseases Diagnostic Business (2015-2020))
  13.1.5 Becton Dickinson & Company Recent Development
13.2 Cepheid, Inc.
  13.2.1 Cepheid, Inc. Company Details
  13.2.2 Cepheid, Inc. Business Overview and Its Total Revenue
  13.2.3 Cepheid, Inc. Infectious Diseases Diagnostic Introduction
  13.2.4 Cepheid, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  13.2.5 Cepheid, Inc. Recent Development
13.3 Abbott Laboratories
  13.3.1 Abbott Laboratories Company Details
  13.3.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.3.3 Abbott Laboratories Infectious Diseases Diagnostic Introduction
  13.3.4 Abbott Laboratories Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  13.3.5 Abbott Laboratories Recent Development
13.4 bioMerieux SA
  13.4.1 bioMerieux SA Company Details
  13.4.2 bioMerieux SA Business Overview and Its Total Revenue
  13.4.3 bioMerieux SA Infectious Diseases Diagnostic Introduction
  13.4.4 bioMerieux SA Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  13.4.5 bioMerieux SA Recent Development
13.5 Hologic, Inc.
  13.5.1 Hologic, Inc. Company Details
  13.5.2 Hologic, Inc. Business Overview and Its Total Revenue
  13.5.3 Hologic, Inc. Infectious Diseases Diagnostic Introduction
  13.5.4 Hologic, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  13.5.5 Hologic, Inc. Recent Development
13.6 Danaher Corporation
  13.6.1 Danaher Corporation Company Details
  13.6.2 Danaher Corporation Business Overview and Its Total Revenue
  13.6.3 Danaher Corporation Infectious Diseases Diagnostic Introduction
  13.6.4 Danaher Corporation Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  13.6.5 Danaher Corporation Recent Development
13.7 Thermo Fisher Scientific, Inc.
  13.7.1 Thermo Fisher Scientific, Inc. Company Details
  13.7.2 Thermo Fisher Scientific, Inc. Business Overview and Its Total Revenue
  13.7.3 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Introduction
  13.7.4 Thermo Fisher Scientific, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  13.7.5 Thermo Fisher Scientific, Inc. Recent Development
13.8 Roche Diagnostics
  13.8.1 Roche Diagnostics Company Details
  13.8.2 Roche Diagnostics Business Overview and Its Total Revenue
  13.8.3 Roche Diagnostics Infectious Diseases Diagnostic Introduction
  13.8.4 Roche Diagnostics Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  13.8.5 Roche Diagnostics Recent Development
13.9 Alera Inc.
  13.9.1 Alera Inc. Company Details
  13.9.2 Alera Inc. Business Overview and Its Total Revenue
  13.9.3 Alera Inc. Infectious Diseases Diagnostic Introduction
  13.9.4 Alera Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  13.9.5 Alera Inc. Recent Development
13.10 DiaSorin S.p.A.
  13.10.1 DiaSorin S.p.A. Company Details
  13.10.2 DiaSorin S.p.A. Business Overview and Its Total Revenue
  13.10.3 DiaSorin S.p.A. Infectious Diseases Diagnostic Introduction
  13.10.4 DiaSorin S.p.A. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  13.10.5 DiaSorin S.p.A. Recent Development
13.11 Quidel Corporation
  10.11.1 Quidel Corporation Company Details
  10.11.2 Quidel Corporation Business Overview and Its Total Revenue
  10.11.3 Quidel Corporation Infectious Diseases Diagnostic Introduction
  10.11.4 Quidel Corporation Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  10.11.5 Quidel Corporation Recent Development
13.12 Bio-Rad Laboratories, Inc.
  10.12.1 Bio-Rad Laboratories, Inc. Company Details
  10.12.2 Bio-Rad Laboratories, Inc. Business Overview and Its Total Revenue
  10.12.3 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Introduction
  10.12.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  10.12.5 Bio-Rad Laboratories, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Infectious Diseases Diagnostic Key Market Segments
Table 2. Key Players Covered: Ranking by Infectious Diseases Diagnostic Revenue
Table 3. Ranking of Global Top Infectious Diseases Diagnostic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infectious Diseases Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Urine
Table 6. Key Players of Blood
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Infectious Diseases Diagnostic Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Infectious Diseases Diagnostic Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Infectious Diseases Diagnostic Players to Combat Covid-19 Impact
Table 13. Global Infectious Diseases Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Infectious Diseases Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Infectious Diseases Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Infectious Diseases Diagnostic Market Share by Regions (2015-2020)
Table 17. Global Infectious Diseases Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Infectious Diseases Diagnostic Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Infectious Diseases Diagnostic Market Growth Strategy
Table 23. Main Points Interviewed from Key Infectious Diseases Diagnostic Players
Table 24. Global Infectious Diseases Diagnostic Revenue by Players (2015-2020) (Million US$)
Table 25. Global Infectious Diseases Diagnostic Market Share by Players (2015-2020)
Table 26. Global Top Infectious Diseases Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Diseases Diagnostic as of 2019)
Table 27. Global Infectious Diseases Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Infectious Diseases Diagnostic Product Solution and Service
Table 30. Date of Enter into Infectious Diseases Diagnostic Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Infectious Diseases Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 33. Global Infectious Diseases Diagnostic Market Size Share by Type (2015-2020)
Table 34. Global Infectious Diseases Diagnostic Revenue Market Share by Type (2021-2026)
Table 35. Global Infectious Diseases Diagnostic Market Size Share by Application (2015-2020)
Table 36. Global Infectious Diseases Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 37. Global Infectious Diseases Diagnostic Market Size Share by Application (2021-2026)
Table 38. North America Key Players Infectious Diseases Diagnostic Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Infectious Diseases Diagnostic Market Share (2019-2020)
Table 40. North America Infectious Diseases Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 41. North America Infectious Diseases Diagnostic Market Share by Type (2015-2020)
Table 42. North America Infectious Diseases Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 43. North America Infectious Diseases Diagnostic Market Share by Application (2015-2020)
Table 44. Europe Key Players Infectious Diseases Diagnostic Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Infectious Diseases Diagnostic Market Share (2019-2020)
Table 46. Europe Infectious Diseases Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Infectious Diseases Diagnostic Market Share by Type (2015-2020)
Table 48. Europe Infectious Diseases Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Infectious Diseases Diagnostic Market Share by Application (2015-2020)
Table 50. China Key Players Infectious Diseases Diagnostic Revenue (2019-2020) (Million US$)
Table 51. China Key Players Infectious Diseases Diagnostic Market Share (2019-2020)
Table 52. China Infectious Diseases Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 53. China Infectious Diseases Diagnostic Market Share by Type (2015-2020)
Table 54. China Infectious Diseases Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 55. China Infectious Diseases Diagnostic Market Share by Application (2015-2020)
Table 56. Japan Key Players Infectious Diseases Diagnostic Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Infectious Diseases Diagnostic Market Share (2019-2020)
Table 58. Japan Infectious Diseases Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Infectious Diseases Diagnostic Market Share by Type (2015-2020)
Table 60. Japan Infectious Diseases Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Infectious Diseases Diagnostic Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Infectious Diseases Diagnostic Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Infectious Diseases Diagnostic Market Share (2019-2020)
Table 64. Southeast Asia Infectious Diseases Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Infectious Diseases Diagnostic Market Share by Type (2015-2020)
Table 66. Southeast Asia Infectious Diseases Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Infectious Diseases Diagnostic Market Share by Application (2015-2020)
Table 68. India Key Players Infectious Diseases Diagnostic Revenue (2019-2020) (Million US$)
Table 69. India Key Players Infectious Diseases Diagnostic Market Share (2019-2020)
Table 70. India Infectious Diseases Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 71. India Infectious Diseases Diagnostic Market Share by Type (2015-2020)
Table 72. India Infectious Diseases Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 73. India Infectious Diseases Diagnostic Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Infectious Diseases Diagnostic Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Infectious Diseases Diagnostic Market Share (2019-2020)
Table 76. Central & South America Infectious Diseases Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Infectious Diseases Diagnostic Market Share by Type (2015-2020)
Table 78. Central & South America Infectious Diseases Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Infectious Diseases Diagnostic Market Share by Application (2015-2020)
Table 80. Becton Dickinson & Company Company Details
Table 81. Becton Dickinson & Company Business Overview
Table 82. Becton Dickinson & Company Product
Table 83. Becton Dickinson & Company Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 84. Becton Dickinson & Company Recent Development
Table 85. Cepheid, Inc. Company Details
Table 86. Cepheid, Inc. Business Overview
Table 87. Cepheid, Inc. Product
Table 88. Cepheid, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 89. Cepheid, Inc. Recent Development
Table 90. Abbott Laboratories Company Details
Table 91. Abbott Laboratories Business Overview
Table 92. Abbott Laboratories Product
Table 93. Abbott Laboratories Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 94. Abbott Laboratories Recent Development
Table 95. bioMerieux SA Company Details
Table 96. bioMerieux SA Business Overview
Table 97. bioMerieux SA Product
Table 98. bioMerieux SA Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 99. bioMerieux SA Recent Development
Table 100. Hologic, Inc. Company Details
Table 101. Hologic, Inc. Business Overview
Table 102. Hologic, Inc. Product
Table 103. Hologic, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 104. Hologic, Inc. Recent Development
Table 105. Danaher Corporation Company Details
Table 106. Danaher Corporation Business Overview
Table 107. Danaher Corporation Product
Table 108. Danaher Corporation Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 109. Danaher Corporation Recent Development
Table 110. Thermo Fisher Scientific, Inc. Company Details
Table 111. Thermo Fisher Scientific, Inc. Business Overview
Table 112. Thermo Fisher Scientific, Inc. Product
Table 113. Thermo Fisher Scientific, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 114. Thermo Fisher Scientific, Inc. Recent Development
Table 115. Roche Diagnostics Business Overview
Table 116. Roche Diagnostics Product
Table 117. Roche Diagnostics Company Details
Table 118. Roche Diagnostics Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 119. Roche Diagnostics Recent Development
Table 120. Alera Inc. Company Details
Table 121. Alera Inc. Business Overview
Table 122. Alera Inc. Product
Table 123. Alera Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 124. Alera Inc. Recent Development
Table 125. DiaSorin S.p.A. Company Details
Table 126. DiaSorin S.p.A. Business Overview
Table 127. DiaSorin S.p.A. Product
Table 128. DiaSorin S.p.A. Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 129. DiaSorin S.p.A. Recent Development
Table 130. Quidel Corporation Company Details
Table 131. Quidel Corporation Business Overview
Table 132. Quidel Corporation Product
Table 133. Quidel Corporation Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 134. Quidel Corporation Recent Development
Table 135. Bio-Rad Laboratories, Inc. Company Details
Table 136. Bio-Rad Laboratories, Inc. Business Overview
Table 137. Bio-Rad Laboratories, Inc. Product
Table 138. Bio-Rad Laboratories, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020) (Million US$)
Table 139. Bio-Rad Laboratories, Inc. Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Infectious Diseases Diagnostic Market Share by Type: 2020 VS 2026
Figure 2. Urine Features
Figure 3. Blood Features
Figure 4. Others Features
Figure 5. Global Infectious Diseases Diagnostic Market Share by Application: 2020 VS 2026
Figure 6. Hospitals and Trauma Centers Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Rehabilitation Centers Case Studies
Figure 9. Infectious Diseases Diagnostic Report Years Considered
Figure 10. Global Infectious Diseases Diagnostic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Infectious Diseases Diagnostic Market Share by Regions: 2020 VS 2026
Figure 12. Global Infectious Diseases Diagnostic Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Infectious Diseases Diagnostic Market Share by Players in 2019
Figure 15. Global Top Infectious Diseases Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Diseases Diagnostic as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Infectious Diseases Diagnostic Revenue in 2019
Figure 17. North America Infectious Diseases Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Infectious Diseases Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Infectious Diseases Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Infectious Diseases Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Infectious Diseases Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Infectious Diseases Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Infectious Diseases Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Becton Dickinson & Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Becton Dickinson & Company Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 26. Cepheid, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Cepheid, Inc. Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 28. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Abbott Laboratories Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 30. bioMerieux SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. bioMerieux SA Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 32. Hologic, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Hologic, Inc. Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 34. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Danaher Corporation Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 36. Thermo Fisher Scientific, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 38. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Roche Diagnostics Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 40. Alera Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Alera Inc. Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 42. DiaSorin S.p.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. DiaSorin S.p.A. Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 44. Quidel Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Quidel Corporation Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 46. Bio-Rad Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Infectious Diseases Diagnostic Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed